[1]
T. Nurseta, P. A. Herliawati, D. E. P. Harnandari, K. Handono, Y. Irwanto, and S. Sutrisno, “Risk of Malignancy Index 3 (RMI3) Performance as a Predictor Advanced Stage Epithelial Ovarian Carcinoma used for NACT: Perfoma Risk of Malignancy Index 3 (RMI3) sebagai Prediktor Karsinoma Ovarium Epithelial Stadium Lanjut untuk Pertimbangan Pemberian NACT”, Indones J Obstet Gynecol, vol. 10, no. 1, pp. 42–48, Jan. 2022.